Chelsea Therapeutics clinical trials
Acquired by H. Lundbeck A/S, Jun 23, 2014 · source ↗
The registry lists 16 studies whose lead sponsor is Chelsea Therapeutics. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 18, 2024.
Before and after it joined H. Lundbeck A/S
- First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- 16
- First submitted after Chelsea Therapeutics became part of H. Lundbeck A/S
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Chelsea Therapeutics16 studies
Something wrong with this grouping? Tell us on the H. Lundbeck A/S page.
Studies
Recruiting first, then most recently updated. Showing 16 of 16. All H. Lundbeck A/S studies →
- Study of Droxidopa Treatment in Adults With Attention Deficit Hyperactivity Disorder With Co-administration of CarbidopaCompletedNCT00983814Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With FibromyalgiaCompletedNCT01323374Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic HypotensionCompletedNCT00657046Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue SyndromeTerminatedNCT00977171Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedNCT01176240Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00738062Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)CompletedNCT01116141Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Study to Assess CH1504 in Patients With Active Rheumatoid ArthritisCompletedNCT00658047Phase 2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's DiseaseWithdrawnNCT01331122Phase 1/2
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- A Multi-Center, Open-Label StudyWithdrawnNCT01468259Phase 1
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of DroxidopaCompletedNCT01149629Phase 1
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S
- Electrocardiographic (ECG) Safety Study of Droxidopa at Clinical and Supratherapeutic DoseCompletedNCT01327066Phase 1
Sponsor listed in the registry: Chelsea Therapeutics · First submitted before Chelsea Therapeutics became part of H. Lundbeck A/S